Smith Andrew Alasdairinsider trades

In SEC Form 4 filings, Smith Andrew Alasdair is listed as Chief Operating Officer of Medicus Pharma Ltd. (MDCX). Smith Andrew Alasdair reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 8.

Companies and roles

Company	Role	Transactions	Last filed
MDCXMedicus Pharma Ltd.	Chief Operating Officer	2	Sep 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
MDCXMedicus Pharma Ltd.	Sep 4	Sep 8	A	735,294	$0.17	$125,368	735,458	No	Form 4
MDCXMedicus Pharma Ltd.	Sep 4	Sep 8	A · derivative	125,000	$0.17	$21,313	125,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.